What's new! CIDG Publications February 2021

One new COVID-19 review, one updated COVID-19 review, and one updated Cochrane review  are in Issue 2, 2021 of the Cochrane Database of Systematic Reviews.

New COVID 19 Review

Singh  B, Ryan  H, Kredo  T, Chaplin  M, Fletcher  T. Chloroquine or hydroxychloroquine for prevention and treatment of COVID19. Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD013587. DOI: 10.1002/14651858.CD013587.pub2

Read the LSTM news story

Updated COVID 19 Review 

Struyf  T, Deeks  JJ, Dinnes  J, Takwoingi  Y, Davenport  C, Leeflang  MMG, Spijker  R, Hooft  L, Emperador  D, Domen  J, Horn  SR A, Van den Bruel  A. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19. Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD013665. DOI: 10.1002/14651858.CD013665.pub2.

Read the Cochrane news story 
Listen to the Cochrane podcast

Updated Cochrane Review 

Zifodya  JS, Kreniske  JS, Schiller  I, Kohli  M, Dendukuri  N, Schumacher  SG, Ochodo  EA, Haraka  F, Zwerling  AA, Pai  M, Steingart  KR, Horne  DJ. Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis. Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.


The CIDG editorial base is located at the Liverpool School of Tropical Medicine  in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. 

The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the  United Nations Sustainable Development Goals